These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 4801225)

  • 41. Cardiovascular effects of aprindine, a new antiarrhythmic drug.
    Remme WJ; Verdouw PD
    Eur J Cardiol; 1975 Dec; 3(4):307-13. PubMed ID: 1193115
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Comparative animal experimental studies of the effectivity of various blood vessel and myocardium ACTIVE SUBSTANCES IN AN ACUTE TRIAL].
    Urbaszek W; Kalkowski H; Günther K; Splith G; Trenckmann H
    Z Gesamte Inn Med; 1969 Feb; 24(4):102-8. PubMed ID: 4978753
    [No Abstract]   [Full Text] [Related]  

  • 43. CL-845 (pirmenol hydrochloride): a new orally effective long-acting antiarrhythmic agent.
    Steffe TJ; Mertz TE; Hastings SG; Potoczak RE; Kaplan HR
    J Pharmacol Exp Ther; 1980 Jul; 214(1):50-7. PubMed ID: 7391970
    [No Abstract]   [Full Text] [Related]  

  • 44. [Effect of ajmaline on ECG, hemodynamics and metabolism in man].
    Benda L; Lujf A; Moser K
    Wien Z Inn Med; 1966 Oct; 47(10):421-6. PubMed ID: 6005176
    [No Abstract]   [Full Text] [Related]  

  • 45. Effects of ajmaline and N-propylajmaline on maximum follow frequency and contractility of the dog heart: short communication.
    Raschack M
    Arzneimittelforschung; 1975 Jun; 25(6):896-8. PubMed ID: 1174325
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Hemodynamic effects of experimental hypercitremia.
    Corbascio AN; Smith NT
    Anesthesiology; 1967; 28(3):510-6. PubMed ID: 6023523
    [No Abstract]   [Full Text] [Related]  

  • 47. [The mechanism of antiarrhythmic action of a new ammonium derivative of lidocaine (LKhT-12-02)].
    Blinov DS; Balashov VP; Sernov LN; Kazachenko VN; Blinova EV; Belova LA; Astashev ME
    Eksp Klin Farmakol; 2006; 69(6):31-3. PubMed ID: 17209461
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Cardiovascular effect of a new antiarrhythmic drug--changrolin (author's transl)].
    Chen WZ; Dong YL; Ding GS
    Yao Xue Xue Bao; 1979 Dec; 14(12):710-4. PubMed ID: 554432
    [No Abstract]   [Full Text] [Related]  

  • 49. Cardiac output, heart rate, and blood pressure as influenced by equi-antiarrhythmic doses of eight antifibrillatory agents.
    Strubelt O; Back G; Uhl E; Zetler G
    Naunyn Schmiedebergs Arch Pharmakol; 1971; 271(4):346-60. PubMed ID: 4257638
    [No Abstract]   [Full Text] [Related]  

  • 50. [Use of the novel taurine derivative for prevention of changes in the systemic hemodynamics induced by electric stimulation of the rabbit aorta].
    Sapronov NS; Novikov VP; Torkunov PA; Siniukhin AB
    Patol Fiziol Eksp Ter; 2000; (4):5-7. PubMed ID: 11247135
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Comparative study of the cardiocirculatory effects and systemic reactions of 4 contrast media used in cineangiocardiography].
    Manfroi WC; Hemb R; Hoeffel JC; Rios SR; de Azevedo DF; de Freitas FM; Faraco EZ
    Arq Bras Cardiol; 1981 Jun; 36(6):417-21. PubMed ID: 7347174
    [No Abstract]   [Full Text] [Related]  

  • 52. Controlled clinical study of the cardiovascular effects of the new local anaesthetic MY 33-7, using a system of multiple simultaneous recordings.
    Allaria B; Citro A; Malavasi G; Perraro F
    Br J Anaesth; 1971 Aug; 43(8):767-72. PubMed ID: 4936344
    [No Abstract]   [Full Text] [Related]  

  • 53. Proceedings: The potentiation of the antiarrhythmic effects of quinidine sulfate, lidocaine and ajmaline by tween 80.
    Rohte O; Jakovljević V
    Naunyn Schmiedebergs Arch Pharmacol; 1974; 282(Suppl):suppl 282:R81. PubMed ID: 4276637
    [No Abstract]   [Full Text] [Related]  

  • 54. [Hemodynamic effects of xylocaine and ajmaline in myocardial infarction].
    Bernard R; Lewinson H; Renta C; Thys JP
    Arch Mal Coeur Vaiss; 1972 Oct; 65(10):1215-8. PubMed ID: 4632665
    [No Abstract]   [Full Text] [Related]  

  • 55. Clinical pharmacology of N,N-bis(phenylcarbamolymethyl)dimethylammonium chloride (QX-572), a new antiarrhythmic agent.
    Schwartz ML; Stapleton J; Covino BG
    J Clin Pharmacol J New Drugs; 1967; 7(5):278-86. PubMed ID: 5237375
    [No Abstract]   [Full Text] [Related]  

  • 56. [Comparative study of the effects of various antiarrhythmic drugs on the frequency of ventricular response during established atrial fibrillation].
    Bracchetti D; Frabetti L; Mambelli M; Stefanini A; Magnani B
    Boll Soc Ital Cardiol; 1977; 22(1):51-5. PubMed ID: 911535
    [No Abstract]   [Full Text] [Related]  

  • 57. Haemodynamic effects of ajmaline in man.
    Saetre H; Ahlmark G; Ahlberg G
    Eur J Clin Pharmacol; 1974 Jul; 7(4):253-7. PubMed ID: 4852211
    [No Abstract]   [Full Text] [Related]  

  • 58. Haemodynamic effects of the antiarrhythmic quaternary ammonium compound QX-572 in man.
    Rydén L; Hjalmarson A ; Kvasnicka J; Liander B
    Br Heart J; 1975 Jan; 37(1):65-73. PubMed ID: 1089426
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Ischaemia-induced loss or reversal of the effects of the class I antiarrhythmic drugs on vulnerability to fibrillation.
    Aupetit JF; Loufoua-Moundanga J; Faucon G; Timour Q
    Br J Pharmacol; 1997 Feb; 120(3):523-9. PubMed ID: 9031759
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Hemodynamic properties of a new derivative of theophylline: bamifylline].
    Moret PR; Fournet PC; Boufas D
    Schweiz Med Wochenschr; 1970 Mar; 100(10):462-7. PubMed ID: 5423732
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.